Sign in to continue:

Saturday, January 31st, 2026

ValueMax Group Allots 14,800 New Shares Following Warrant Exercise at S$0.36 Each

ValueMax Group Limited Announces Share Allotment Following Warrant Exercise

ValueMax Group Limited Announces Share Allotment Following Warrant Exercise

Key Highlights

  • Increase in Issued Share Capital: ValueMax Group Limited has increased its total issued ordinary shares from 940,868,539 (excluding 100,000 treasury shares) to 940,883,339 ordinary shares.
  • New Shares Issued: The increase is due to the allotment and issuance of 14,800 new ordinary shares following the exercise of 14,800 warrants at an exercise price of S\$0.36 per share on 22 January 2026.
  • Listing of New Shares: These new shares, which will rank pari passu with existing shares, are scheduled to be listed and quoted on the Singapore Exchange Securities Trading Limited (SGX-ST) on 26 January 2026.
  • Outstanding Warrants: Following this exercise, there remain 6,921,970 outstanding warrants (each at S\$0.36 exercise price), expiring at 5:00 p.m. on 14 September 2026.

Details Investors Should Note

  • Potential Dilution: The issuance of new shares will result in a slight dilution of existing shareholders’ equity. While the increase is minimal (14,800 shares relative to the total issued shares), investors should be aware of the ongoing potential for further dilution as the outstanding warrants may be exercised before expiry.
  • Capital Raising: The exercise price of S\$0.36 per share may provide the company with additional capital as more warrants are exercised. This could strengthen the company’s cash position and support future growth initiatives.
  • Price Sensitivity: The ongoing presence of a substantial number of outstanding warrants (6.9 million) could exert pressure on the share price, particularly as expiry approaches and if the market price is well above the exercise price. Investors should monitor warrant exercise activity, as larger exercises may signal confidence in the company or could lead to further dilution and potential downward pressure on the share price.
  • Shareholder Impact: The new shares will enjoy the same rights as existing shares, including voting rights and entitlements to any distributions or dividends declared.
  • Timeframe: The next major date for warrant holders is 14 September 2026, the final exercise deadline. Shareholders should pay attention to any significant warrant exercises before this date, as they may indicate strategic moves by major stakeholders or insiders.

Implications for Shareholders and Potential Share Price Movement

The announcement of additional shares being issued through warrant exercise is a routine but potentially price-sensitive event. While the number of shares issued in this round is relatively small, the existence of a large pool of outstanding warrants could impact the company’s capital structure and share price over the coming months. Investors should assess the likelihood of further warrant exercises and the company’s use of any new capital raised.

If the company’s share price remains above S\$0.36, further exercise of warrants is probable, which could lead to incremental dilution. Conversely, frequent warrant exercises may also signal investor confidence in ValueMax Group Limited’s prospects, possibly supporting a higher valuation.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a financial advisor before making investment decisions. The author is not responsible for any losses incurred as a result of actions taken based on this information.


View ValueMax W260914 Historical chart here



Metech International Limited Provides September 2025 Business Update: CFO Appointment, Disposal of Diamond Business, New Health Supplements Channel, and Loan Repayment Plans 1

Metech International’s Strategic Overhaul: Exits Lab-Grown Diamonds, Eyes Food Waste and Health Supplements Expansion Key Highlights from September 2025 Update Exiting the Unviable Lab-Grown Diamond Business Potential Disposal of Major Subsidiaries in Singapore and...

LHN Limited Announces SGD 0.01 Final Dividend for FY2024 with Key Dates for Shareholders

LHN Limited Declares Final Dividend With Key Dates Announced LHN Limited Declares Final Dividend With Key Dates Announced LHN Limited has announced a final ordinary dividend of SGD 0.01 per share for the financial...

Camsing Healthcare Limited 2025 AGM Minutes – Key Resolutions, Directors’ Re-election, and Shareholder Voting Results

Camsing Healthcare AGM: Unanimous Shareholder Support for Board, Auditors, and New Share Issuance Mandate Camsing Healthcare AGM: Unanimous Shareholder Support Signals Stability, Growth Ambitions Key Takeaways from Camsing Healthcare Limited’s 2025 Annual General Meeting...